Opinion | Published:

Use the Bayh-Dole Act to lower drug prices for government healthcare programs

Nature Medicine volume 22, page 576 (2016) | Download Citation

As drug prices have increased, there is also greater pressure to find ways to ensure access to medicines. An existing provision of the Bayh-Dole Act could help to lower costs for qualifying drugs in federal programs such as Medicare and Medicaid.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    UCLA will get hundreds of millions for rights to prostate cancer drug. LA Times (4 March 2016).

  2. 2.

    .

  3. 3.

    28 U.S.C. § 1498(a) (2015).

  4. 4.

    Gore v. Garlock, 842 F.2d 1275, 1282 (Fed. Cir. 1988).

Download references

Author information

Affiliations

  1. Alfred B. Engelberg is a trustee at the Engelberg Foundation in Palm Beach, Florida, and

    • Alfred B Engelberg
  2. Aaron S. Kesselheim is an associate professor of medicine at the Brigham and Women's Hospital and Harvard Medical School in Boston.

    • Aaron S Kesselheim

Authors

  1. Search for Alfred B Engelberg in:

  2. Search for Aaron S Kesselheim in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm0616-576

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing